These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 27989621)
21. Molecular basis of the head-to-tail assembly of giant muscle proteins obscurin-like 1 and titin. Sauer F; Vahokoski J; Song YH; Wilmanns M EMBO Rep; 2010 Jul; 11(7):534-40. PubMed ID: 20489725 [TBL] [Abstract][Full Text] [Related]
22. When is an obscurin variant pathogenic? The impact of Arg4344Gln and Arg4444Trp variants on protein-protein interactions and protein stability. Fukuzawa A; Koch D; Grover S; Rees M; Gautel M Hum Mol Genet; 2021 Jun; 30(12):1131-1141. PubMed ID: 33438037 [TBL] [Abstract][Full Text] [Related]
23. Early incorporation of obscurin into nascent sarcomeres: implication for myofibril assembly during cardiac myogenesis. Borisov AB; Martynova MG; Russell MW Histochem Cell Biol; 2008 Apr; 129(4):463-78. PubMed ID: 18219491 [TBL] [Abstract][Full Text] [Related]
24. Molecular interactions with obscurin are involved in the localization of muscle-specific small ankyrin1 isoforms to subcompartments of the sarcoplasmic reticulum. Armani A; Galli S; Giacomello E; Bagnato P; Barone V; Rossi D; Sorrentino V Exp Cell Res; 2006 Nov; 312(18):3546-58. PubMed ID: 16962094 [TBL] [Abstract][Full Text] [Related]
25. Localization of ank1.5 in the sarcoplasmic reticulum precedes that of SERCA and RyR: relationship with the organization of obscurin in developing sarcomeres. Giacomello E; Sorrentino V Histochem Cell Biol; 2009 Mar; 131(3):371-82. PubMed ID: 19002483 [TBL] [Abstract][Full Text] [Related]
26. Structural analysis of obscurin gene in hypertrophic cardiomyopathy. Arimura T; Matsumoto Y; Okazaki O; Hayashi T; Takahashi M; Inagaki N; Hinohara K; Ashizawa N; Yano K; Kimura A Biochem Biophys Res Commun; 2007 Oct; 362(2):281-7. PubMed ID: 17716621 [TBL] [Abstract][Full Text] [Related]
27. Obscurin is a semi-flexible molecule in solution. Whitley JA; Ex-Willey AM; Marzolf DR; Ackermann MA; Tongen AL; Kokhan O; Wright NT Protein Sci; 2019 Apr; 28(4):717-726. PubMed ID: 30666746 [TBL] [Abstract][Full Text] [Related]
28. Structural Insights on the Obscurin-Binding Domains in Titin. Letourneau AG; Wright NT Protein Pept Lett; 2018; 25(11):973-979. PubMed ID: 30289063 [TBL] [Abstract][Full Text] [Related]
29. The sarcomeric cytoskeleton: who picks up the strain? Gautel M Curr Opin Cell Biol; 2011 Feb; 23(1):39-46. PubMed ID: 21190822 [TBL] [Abstract][Full Text] [Related]
30. Novel OBSCN variants associated with a risk to exercise-intolerance and rhabdomyolysis. Zemorshidi F; Töpf A; Claeys KG; McFarlane A; Patton A; Nafissi S; Straub V Neuromuscul Disord; 2024 Jan; 34():83-88. PubMed ID: 38159459 [TBL] [Abstract][Full Text] [Related]
31. Dynamics of obscurin localization during differentiation and remodeling of cardiac myocytes: obscurin as an integrator of myofibrillar structure. Borisov AB; Kontrogianni-Konstantopoulos A; Bloch RJ; Westfall MV; Russell MW J Histochem Cytochem; 2004 Sep; 52(9):1117-27. PubMed ID: 15314079 [TBL] [Abstract][Full Text] [Related]
32. Nuclear localization of Myomesin-1: possible functions. Reddy KB; Fox JE; Price MG; Kulkarni S; Gupta S; Das B; Smith DM J Muscle Res Cell Motil; 2008; 29(1):1-8. PubMed ID: 18521710 [TBL] [Abstract][Full Text] [Related]
33. The structure of the sarcomeric M band: localization of defined domains of myomesin, M-protein, and the 250-kD carboxy-terminal region of titin by immunoelectron microscopy. Obermann WM; Gautel M; Steiner F; van der Ven PF; Weber K; Fürst DO J Cell Biol; 1996 Sep; 134(6):1441-53. PubMed ID: 8830773 [TBL] [Abstract][Full Text] [Related]
34. Obscurin determines the architecture of the longitudinal sarcoplasmic reticulum. Lange S; Ouyang K; Meyer G; Cui L; Cheng H; Lieber RL; Chen J J Cell Sci; 2009 Aug; 122(Pt 15):2640-50. PubMed ID: 19584095 [TBL] [Abstract][Full Text] [Related]
35. Superhelical architecture of the myosin filament-linking protein myomesin with unusual elastic properties. Pinotsis N; Chatziefthimiou SD; Berkemeier F; Beuron F; Mavridis IM; Konarev PV; Svergun DI; Morris E; Rief M; Wilmanns M PLoS Biol; 2012 Feb; 10(2):e1001261. PubMed ID: 22347812 [TBL] [Abstract][Full Text] [Related]
36. The M-band: The underestimated part of the sarcomere. Lange S; Pinotsis N; Agarkova I; Ehler E Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118440. PubMed ID: 30738787 [TBL] [Abstract][Full Text] [Related]
37. Obscurin modulates the assembly and organization of sarcomeres and the sarcoplasmic reticulum. Kontrogianni-Konstantopoulos A; Catino DH; Strong JC; Sutter S; Borisov AB; Pumplin DW; Russell MW; Bloch RJ FASEB J; 2006 Oct; 20(12):2102-11. PubMed ID: 17012262 [TBL] [Abstract][Full Text] [Related]
38. Molecular basis of the C-terminal tail-to-tail assembly of the sarcomeric filament protein myomesin. Pinotsis N; Lange S; Perriard JC; Svergun DI; Wilmanns M EMBO J; 2008 Jan; 27(1):253-64. PubMed ID: 18059477 [TBL] [Abstract][Full Text] [Related]
39. Murine obscurin and Obsl1 have functionally redundant roles in sarcolemmal integrity, sarcoplasmic reticulum organization, and muscle metabolism. Blondelle J; Marrocco V; Clark M; Desmond P; Myers S; Nguyen J; Wright M; Bremner S; Pierantozzi E; Ward S; Estève E; Sorrentino V; Ghassemian M; Lange S Commun Biol; 2019; 2():178. PubMed ID: 31098411 [TBL] [Abstract][Full Text] [Related]
40. Myomesin is part of an integrity pathway that responds to sarcomere damage and disease. Prill K; Carlisle C; Stannard M; Windsor Reid PJ; Pilgrim DB PLoS One; 2019; 14(10):e0224206. PubMed ID: 31644553 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]